A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions

Osteoarthritis

Interventions

DRUG

VX-150

DRUG

Placebo

Trial Locations (12)

San Diego

West Palm Beach

Marietta

Valparaiso

Wichita

Bay City

Las Vegas

Hartsdale

Duncansville

Providence

Chattanooga

Danville

All Listed Sponsors

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT02660424 - A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter